UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 22, 2004
--------------------------
Merck & Co., Inc.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
New Jersey
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-3305 22-1109110
--------------------------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
One Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code (908) 423-1000
-----------------------------
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit 99.1 Press release issued April 22, 2004 regarding earnings for
first quarter 2004
Exhibit 99.2 Certain supplemental information not included in the press
release
Item 9. Regulation FD Disclosure; and
Item 12. Results of Operations and Financial Condition.
The following information is being furnished pursuant to both Item 9 and Item
12.
Incorporated by reference is a press release issued by the Registrant on April
22, 2004, regarding earnings for the first quarter 2004, attached as Exhibit
99.1. Also incorporated by reference is certain supplemental information not
included in the press release, attached as Exhibit 99.2.
This information shall not be deemed to be "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that Section, and is not incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such
filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Merck & Co., Inc.
Date: April 22, 2004 By: /s/ Debra A. Bollwage
-----------------------
DEBRA A. BOLLWAGE
Assistant Secretary
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99.1 Press release issued April 22, 2004 regarding earnings for
first quarter 2004
99.2 Certain supplemental information not included in the press
release